摘要
目的探讨慢性阻塞性肺疾病应用糖皮质激素联合特布他林治疗的临床效果。方法随机抽取2016年4月—2017年4月本院收治的慢性阻塞性肺疾病患者72例作为研究对象。按照治疗方法的不同,将72例患者分为研究组(糖皮质激素+特布他林,n=36)与对照组(特布他林,n=36)。对比两组患者的治疗效果。结果研究组、对照组总有效率分别为97.2%、83.3%,组间数据对比,差异具有统计学意义(P<0.05);治疗后,研究组患者肺功能各指标均优于对照组,差异具有统计学意义(P<0.05);研究组患者的不良反应发生率少于对照组,差异具有统计学意义(P<0.05)。结论糖皮质激素联合特布他林治疗慢性阻塞性肺疾病的效果理想。
Objective To investigate the clinical effect of glucocorticoid combined with terbutaline in the treatment of chronic obstructive pulmonary disease. Methods A total of 72 patients with chronic obstructive pulmonary disease admitted in our hospital from April 2016 to April 2017 were randomly selected. According to different treatment methods, 72 patients were divided into study group（glucocorticoid ＋ terbutaline, n=36） and control group（terbutaline, n=36）. The therapeutic effects of the two groups were compared. Results The total effective rates of the study group and the control group were 97.2% and 83.3% respectively, and the difference between the two groups was statistically significant（P 0.05）; After treatment, the indexes of lung function in the study group were better than those in the control group, the difference was statistically significant（P 〈 0.05）; The incidence of adverse reactions in the study group was less than that in the control group, and the difference was statistically significant（P 〈 0.05）. Conclusion The effect of glucocorticoid combined with terbutaline in the treatment of chronic obstructive pulmonary disease is ideal.
出处
《中国继续医学教育》
2017年第27期106-107,共2页
China Continuing Medical Education
关键词
慢性阻塞性肺疾病
糖皮质激素
特布他林
chronic obstructive pulmonary disease
glucocorticoids
terbutaline
